TORONTO, ON — As the medical community continues to make strides in early detection and acute treatment...
Patient Advocacy and Support
By Douglas Feil, NBCF Chief Program Officer The landscape of chronic disease management has been significantly reshaped...
NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October,...
The landscape of metastatic breast cancer (MBC) treatment has undergone a significant transformation with the recent U.S....
TORONTO, ON — As the medical community continues to make strides in the early detection and treatment...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have rapidly ascended...
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
In a landmark decision that promises to reshape the standard of care for patients battling advanced malignancy,...
TORONTO, ON – As the medical community continues to make strides in early detection and targeted therapies,...
Introduction: A Growing Intersection of Health and Hope In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists, commonly...
